There is literature proving that Fbxo45 is also associated with the poor prognosis of gastric cancer and degradation of EMT‐related transcriptional factors in breast cancer or prostate cancer [35, 67, 68]. This evidence concerns the gene FBXO45 and prostate carcinoma.